Financial Enhancement Group LLC
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1641438
ANDERSON, IN
Position in KNSA
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$2,007,454
New position
Shares Held
31,391
first reported quarter
Ownership
0.020%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#2
of 13 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Financial Enhancement Group LLC holds $2,007,454 across 1 Drug Manufacturers - Specialty & Generic name. KNSA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
31,391 | $2,007,454 |
All Filings in KNSA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,007,454 | 31,391 | Shares | Sole | 2026-07-07 | |
| No filing history on record for this holder in this stock. | ||||||